Ameriprise
ONEM

Ameriprise’s 1Life Healthcare ONEM Stock Holding History

Ameriprise’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-163,578
Closed -$2.73M – 4073
2022
Q4 		$2.73M Sell
163,578
-14,653
-8% -$248K ﹤0.01% 2665
2022
Q3 		$3.06M Buy
+178,231
New +$2.8M ﹤0.01% 2564
2021
Q4 		– Sell
-162,546
Closed -$3.29M – 4078
2021
Q3 		$3.29M Sell
162,546
-7,378
-4% -$190K ﹤0.01% 2645
2021
Q2 		$5.62M Sell
169,924
-31,083
-15% -$1.17M ﹤0.01% 2367
2021
Q1 		$7.86M Buy
201,007
+28,702
+17% +$1.35M ﹤0.01% 2069
2020
Q4 		$7.52M Buy
172,305
+53,447
+45% +$1.83M ﹤0.01% 1974
2020
Q3 		$3.37M Sell
118,858
-2,611
-2% -$82.4K ﹤0.01% 2351
2020
Q2 		$4.41M Buy
121,469
+2,044
+2% +$57.6K ﹤0.01% 2150
2020
Q1 		$2.17M Buy
+119,425
New +$2.62M ﹤0.01% 2434

Ameriprise's ONEM Position: Q1 2023 in Review

Ameriprise sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 163,578 shares — an estimated $2.73M sold.

Ameriprise first reported a position in ONEM in Q1 2020 and held it in 9 quarters. The position peaked at $7.86M in Q1 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Ameriprise reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Ameriprise sold 163,578 1Life Healthcare shares in Q1 2023, an estimated $2.73M.
  • Ameriprise first reported a position in 1Life Healthcare in Q1 2020 and held it in 9 quarters.
  • Ameriprise's 1Life Healthcare position peaked at $7.86M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Ameriprise's 13F filing for Q1 2023, filed 15 May 2023.